11/11/2008 News For: In Vitro Fertilization PricesSafeguard Scientifics And Oxford Bioscience Partners Co-Lead $12M Series A FINANCING FOR Molecular Biometrics Safeguard Scientifics, Inc., recently announced it co-led a $12M Series A financing round with Oxford Bioscience Partners for Molecular Biometrics, Inc. The metabolomics company's lead product, ViaMetrics-E, is a diagnostic procedure designed to help identify the most viable embryos with the greatest reproductive potential for in vitro fertilization IVF. Falling Gas Prices Bring Smiles To Oxford Drivers Falling gas prices, attributed to fading world-wide energy demand, appear to be fueling a slight increase in some businesses. That's what Ron Sanders found in the central Massachusetts town of Oxford where gas dipped below $2 a gallon yesterday and dropped even farther today. New Path Found To Antibiotics In Dirt A teaspoon of dirt contains an estimated 10,000 species of bacteria, but it's only one percent of these microbial bugs -- the ones that can be grown easily in a lab -- that have brought us antibiotics, anticancer agents and other useful drugs. Victim of shooting near JMU still in critical condition A Staunton man remains in critical condition today at the University of Virginia Medical Center after he was shot in the head early Sunday near the James Madison University campus in Harrisonburg. Cindy Wood, a family friend, is organizing a fund-raiser to help with medical expenses for 19-year-old Reginald "Shay" Nicholson, a former star running back at Robert E. Lee High School. Bayer's Xarelto shows encouraging results in patients with acute coronary syndrome Findings from the ATLAS ACS TIMI 46 study - a phase-II study of the novel oral anticoagulant Xarelto rivaroxaban - were presented as a late-breaking clinical trial at the American Heart Association's Scientific Sessions 2008 in New Orleans by C Michael Gibson, director of the TIMI Data Coordinating Center, Harvard Medical School, Boston, Massachusetts, USA. Results from this phase-II study ... TAC: Vaccine prices a killer Thousands of lives could be saved if prices for the vaccine against cervical cancer - which can cost more than R2 000 - were reduced, the TAC says. High vaccine prices costing lives - TAC Treatment Action Campaign believes that thousands of lives could be saved if prices for the vaccine against cervical cancer were reduced. High vaccine prices costing lives - TAC Thousands of lives could be saved if prices for the vaccine against cervical cancer were reduced, the Treatment Action Campaign TAC said on Tuesday. Saudi Arabia Sues Cigarette Importers for $34 Billion Saudi Arabia's Health Ministry has filed a $34 billion lawsuit against importers of cigarettes from international tobacco companies, including U.S. firms, for costs of medical treatment of smoking-related illnesses, the first such action in the Arab world and one of the world's biggest damage claims. The health and economic costs of tobacco-related illnesses in the kingdom total more than $1.3 ... |


